Earth Science Tech, Inc. (OTC: ETST), a strategic holding company operating in regulated healthcare markets, has announced an engagement with InvestorBrandNetwork (IBN) to support its corporate communications strategy. This move reflects the company's focus on execution, compliance, and disciplined scaling across its diverse portfolio of healthcare businesses.
The company operates through wholly owned and majority-owned subsidiaries that include RxCompoundStore.com, LLC, Peaks Curative, LLC, Avenvi, LLC, Mister Meds, LLC, Earth Science Foundation, Inc., Las Villas Health Care, Inc., DOConsultations, LLC., and maintains an 80% interest in MagneChef. These operations span licensed pharmaceutical compounding, digital health and telemedicine platforms, specialty healthcare services, and complementary assets, with hands-on operational oversight aimed at building sustainable revenue streams and long-term shareholder value.
IBN, a multifaceted financial news and publishing company, will provide corporate communications support through its specialized platform BioMedWire, which focuses on developments in biotechnology, biomedical sciences, and life sciences sectors. As part of the Dynamic Brand Portfolio at IBN, BioMedWire delivers access to wire solutions via InvestorWire, article syndication to over 5,000 outlets, enhanced press release services, social media distribution to millions of followers, and tailored corporate communications solutions.
This partnership is significant for investors and industry observers as it represents Earth Science Tech's commitment to transparent communication during its expansion phase. The company's latest news and updates relating to ETST are available in the company's newsroom at https://ibn.fm/ETST, providing stakeholders with centralized access to corporate developments.
The engagement with IBN comes at a time when effective corporate communication is increasingly important for companies operating in regulated healthcare markets. Earth Science Tech's diverse portfolio across pharmaceutical compounding, telemedicine, and real estate development requires clear messaging to investors, regulators, and the healthcare community. The company's strategic approach to building sustainable revenue streams through operational oversight of its subsidiaries positions it within competitive healthcare sectors where regulatory compliance and market communication are critical success factors.
For more information about BioMedWire, the specialized communications platform within IBN that will be supporting Earth Science Tech, visit https://www.BioMedWire.com. The full terms of use and disclaimers applicable to all content provided by BMW are available at https://www.BioMedWire.com/Disclaimer.
